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Sensitivity, Specificity, and Sex Differences in Symptoms Reported on
the 13-Item Acute Coronary Syndrome Checklist
Holli A. DeVon, PhD, RN, FAHA, FAAN; Anne Rosenfeld, PhD, RN, FAAN, FAHA; Alana D. Steffen, PhD; Mohamud Daya, MD, MS
Background-—Clinical symptoms are part of the risk stratification approaches used in the emergency department (ED) to evaluate
patients with suspected acute coronary syndromes (ACS). The objective of this study was to determine the sensitivity, specificity,
and predictive value of 13 symptoms for a discharge diagnosis of ACS in women and men.
Methods and Results-—The sample included 736 patients admitted to 4 EDs with symptoms suggestive of ACS. Symptoms were
assessed with the 13-item validated ACS Symptom Checklist. Mixed-effects logistic regression models were used to estimate
sensitivity, specificity, and predictive value of each symptom for a diagnosis of ACS, adjusting for age, obesity, diabetes, and
functional status. Patients were predominantly male (63%) and Caucasian (70.5%), with a mean age of 59.714.2 years. Chest
pressure, chest discomfort, and chest pain demonstrated the highest sensitivity for ACS in both women (66%, 66%, and 67%) and
men (63%, 69%, and 72%). Six symptoms were specific for a non-ACS diagnosis in both women and men. The predictive value of
shoulder (odds ratio [OR]=2.53; 95% CI=1.29 to 4.96) and arm pain (OR 2.15; 95% CI=1.10 to 4.20) in women was nearly twice
that of men (OR=1.11; 95% CI=0.67 to 1.85 and OR=1.21; 95% CI=0.74 to 1.99). Shortness of breath (OR=0.49; 95% CI=0.30 to
0.79) predicted a non-ACS diagnosis in men.
Conclusions-—There were more similarities than differences in symptom predictors of ACS for women and men. ( J Am Heart
Assoc. 2014;3:e000586 doi: 10.1161/JAHA.113.000586)
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P atients presenting to the emergency department (ED)with undifferentiated chest pain or other symptoms
suggestive of acute coronary syndromes (ACS) account for
10% of all ED visits1 and present a diagnostic challenge.2,3
ACS, an umbrella term used to denote the spectrum of
myocardial ischemia, includes unstable angina, non-ST-eleva-
tion myocardial infarction, and ST-elevation myocardial
infarction.4 Rapid triage for this potentially life-threatening
condition is paramount for effective time-dependent reperfu-
sion therapies that reduce mortality and morbidity.5 Though a
missed ACS diagnosis is rare (2.1% to 5.3%), consequences
are serious with a 2-fold higher risk of 30-day mortality for
patients with ACS inappropriately discharged from the ED.3,6
Self-reported symptoms are the primary method by which
patients communicate to clinicians the nature of their
problem. Therefore, symptoms have the potential to augment
traditional clinical features and risk stratification tools in
predicting the likelihood of ACS.
Symptoms of ACS have been widely described in the
literature.7 The classic symptoms of ACS, as endorsed by the
American Heart Association (AHA) and the American College
of Cardiology (ACC), are chest discomfort, discomfort in other
areas of the upper body, shortness of breath, cold sweat,
nausea, and lightheadedness.4,8 These symptoms have tradi-
tionally been used to aid in risk stratification and acceleration
of care for patients presenting to the ED with symptoms
suggestive of ACS.9 Findings from studies using predictive
models to assess the value of symptoms for a diagnosis of
acute myocardial infarction (AMI) or ACS have varied. Some
studies found that chest pain, shoulder pain, arm pain,
sweating, nausea, and vomiting are predictive of AMI/ACS,
but findings are not uniform across studies.10–14 Attention to
classic symptoms, in particular chest pain, may disadvantage
women, the elderly, and individuals with diabetes, who may
From the College of Nursing, University of Illinois at Chicago, Chicago, IL
(H.A.D., A.D.S.); College of Nursing, University of Arizona, Tucson, AZ (A.R.);
Oregon Health & Science University, Portland, OR (M.D.).
These findings were reported at AHA Scientific Sessions in Dallas, TX on
November 18, 2013.
Correspondence to: Holli A. DeVon, PhD, RN, FAHA, FAAN, College of
Nursing, University of Illinois at Chicago, 845 S. Damen Ave, M/C 802,
Chicago, IL 60612. E-mail: hdevon1@uic.edu
Received October 8, 2013; accepted February 10, 2014.
ª 2014 The Authors. Published on behalf of the American Heart Association,
Inc., by Wiley Blackwell. This is an open access article under the terms of the
Creative Commons Attribution-NonCommercial License, which permits use,
distribution and reproduction in any medium, provided the original work is
properly cited and is not used for commercial purposes.
DOI: 10.1161/JAHA.113.000586 Journal of the American Heart Association 1
ORIGINAL RESEARCH
experience less-typical symptoms15,16 or suffer from silent
ischemia.17 However, identification of symptoms that are
sensitive and specific to ACS has the potential to reduce
treatment-seeking delay and potentially expedite triage and
diagnostic testing.
Most studies examining the sensitivity of symptoms
associated with ACS solely recruited patients with a con-
firmed diagnosis,18–21 limiting the ability to assess specificity.
Specificity of ACS symptoms has been assumed to be low in
women, but has not been confirmed.22 In addition, the
predictive value of symptoms is more useful than sensitivity
from a clinical perspective because it is the probability that a
person with the symptom actually has the associated
illness.23 The objective of this analysis was to determine
the sensitivity, specificity, and predictive values of 13
previously validated symptoms for a diagnosis of ACS in
women and men presenting to the ED.
Methods
This analysis is part of a larger prospective, multicenter study
examining the influence of sex on symptom characteristics
during ACS. Patients were enrolled at 4 large medical centers;
1 in the Midwest, 2 in the Pacific Northwest, and 1 in the West
regions of the United States. Three were academic medical
centers, and the second Northwest site was a large commu-
nity medical center. Approval from all 4 institutional review
boards was received before the start of the study, and all
participants gave written informed consent. Each institutional
review board approved a waiver of initial consent for
electronic screening of patients at triage and to collect initial
symptom data before enrollment. A waiver of initial consent
was granted because the main study aim was to evaluate
symptoms on presentation to the ED and because the
emergent nature of patients presenting with possible ACS
precluded the provision of immediate informed consent. All
patients were enrolled when they were deemed to be stable
by the primary nurse or physician and had been transferred to
a private examination room in either the ED or hospital.
Initially collected symptom data were destroyed if the patient
subsequently declined to participate.
Study Population
Individuals presenting to the ED between January 2011 and
March 2013 with symptoms triggering an ACS evaluation
and who were ≥21 years, fluent in English, and arrived by
emergency medical services, private, or public transportation
were eligible. Patients were excluded if they had an underlying
exacerbation of heart failure (defined as BNP ≥500 pg/mL),
were transferred from a hemodialysis facility, were being
evaluated for a dysrhythmia, were non-English speaking, or
had cognitive impairment (defined as the inability to under-
stand and provide written informed consent for the study).
Because most patients presenting to the ED for symptoms
suggestive of ACS will be ruled out, a targeted sampling plan
was implemented for this study. Patients most likely to be
ruled in were identified before enrollment based on standard
ECG and troponin criteria.24 Those patients with any ECG
changes suggestive of ischemia and/or with a troponin level
outside the referenced norm for the institution were
approached for enrollment. Ischemia was defined as new ST
elevation at the J point ≥0.1 mV in 2 contiguous leads and/or
new horizontal or down-sloping ST depression ≥0.05 mV in 2
contiguous leads and/or T inversion ≥0.1 mV in 2 contiguous
leads with prominent R wave.24 Discharge diagnoses (ACS
versus non-ACS) were based on the clinical judgment of the
ED physician for patients discharged from the ED and the
attending physician for patients who were admitted. Physi-
cians remained unaware of the symptom data collected by the
researchers. Discharge diagnoses were abstracted from the
medical record by trained research associates who were
clinical experts and were also blinded to the research data.
Equivocal or discrepant discharge diagnoses were adjudicated
by 3 of the authors (M.D., H.D., and A.R.). Clinical data on self-
reported comorbid factors, such as diabetes and hyperten-
sion, were confirmed from the medical record. If there were
discrepancies, only the data from the medical record were
used for the analyses.
Measures
The ACS Symptom Checklist is a 13-item validated instrument
that measures symptoms of ACS.19,25 Participants indicate
whether the symptom is present or absent. Symptoms not
appearing on the checklist can be recorded in a blank space
marked “other.” Each symptom is analyzed individually, and
there is no summary score. The ACS Symptom Checklist is
derived from the Symptoms of Acute Coronary Syndromes
Index (SACSI). The SACSI, a reliable and valid instrument, has
been tested in previous studies.19,25 Participants indicated
whether the symptom was present or absent. Symptoms not
listed on the checklist were recorded in a blank space marked
“other.” A content validity index of 1.00 (P<0.05) using Lynn’s
formula26 was calculated based on responses from 11
experts. One item, heat sensation, was judged irrelevant
and removed from the original 14-item checklist.
Patient baseline characteristics were collected using the
ACS Patient Information Questionnaire. This demographic and
clinical questionnaire was designed using the standardized
reporting guidelines recommended for studies evaluating risk
stratification of ED patients with potential ACS.27 These
guidelines were established by the Multidisciplinary Standard-
ized Reporting Criteria Task Force and are supported by the
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Society for Academic Emergency Medicine, the American
College of Emergency Physicians, the AHA, and the ACC.
The purpose of the questionnaire is to establish standardized
reporting criteria that will allow for easier comparisons across
studies and also facilitate meta-analyses. Functional status
was measured with the Duke Activity Status Index (DASI).28
The DASI is a brief 12-item instrument that measures
functional capacity. Scores range from 0 to 58.2, with higher
scores representing better physical functioning. The items on
the scale are weighted to reflect metabolic energy expendi-
ture and correlate highly with peak VO2 (r=0.80; P<0.0001)
28
in patients with ACS,29 ischemic heart disease,30 heart
failure,31 and revascularization procedures.32
Procedures
A trained member of the study research team completed the
ACS symptom checklist shortly after the patient was triaged in
the ED. Patients were enrolled between 0700 and 2300 every
day. In most cases, symptoms were assessed within 15 min-
utes of ED presentation. Patients were then formally
approached by the research staff for enrollment after they
were deemed stable and placed in an ED examination room or
in their hospital room. The study purpose was then explained,
and once the patient provided written informed consent,
additional clinical and individual characteristics were recorded.
Statistical Analysis
To address power concerns for differences in symptoms
between patients ruled in and ruled out for ACS, a sample size
of 261 per group (n=522) was needed for 80% power to
detect a small effect size (d=0.25) using ANOVA with a 0.05
2-sided level of significance. Because the primary purpose of
the study was sex differences in symptoms, we aimed to
enroll an equal amount of women and men. Study data were
entered into SAS. Significance was set at P<0.05 for all
statistical procedures. Demographic and clinical characteris-
tics were described for the total sample and also compared by
groups defined by ACS diagnosis and sex using chi-square
tests for independence, independent samples t tests, and
Wilcoxon rank sums tests.
Sensitivity was defined as the probability of the presence
of a symptom among patients with a confirmed diagnosis of
ACS. Specificity was defined as the probability of the absence
of a symptom among patients ruled out for ACS. Sensitivity
and specificity were computed for each of the 13 symptoms.
Sensitivity and specificity are usually calculated as simple
proportions using a 292 cross-tabulation of symptom
(present, absent) versus diagnosis (ACS, no ACS); however,
data collection sites varied on the proportion of patients ruled
in for ACS (P<0.0001). Therefore, mixed-effects logistic
regression models, including random intercepts to control
for site differences, were used to estimate the sensitivity and
specificity of each symptom for a confirmed ACS diagnosis.
Models were tested for the entire sample and then stratified
by sex. A sensitivity and specificity of ≥60% were considered
to be moderately high for this sample based on previous
studies of the sensitivity and specificity of symptoms for a
diagnosis in a variety of conditions.33–36 This range is also
consistent with sensitivities and specificities reported in
Bruyninckx’s meta-analysis.37 Similar logistic regression mod-
els were used to estimate the odds ratios (ORs) of each
symptom as a predictor of an ACS diagnosis controlling for
age, obesity, diabetes, functional status, and sex. A sex by
symptom interaction term was evaluated to determine
whether the relationship between symptoms and diagnosis
varied between women and men. Potential covariates were
chosen based on sex differences in previous studies and
because age, obesity, functional status, and diabetes can
confound the symptom experience.38,39
Results
Sample Characteristics
The sample (n=736) included 301 patients (40.9%) ruled in
and 435 (59.1%) ruled out for ACS. A total of 10 896 patients
were screened. Of the 1005 patients eligible to participate,
269 (26.8%) declined (Figure). The most common reason
given was stress, discomfort, or fatigue. Of the 301 patients
who ruled in for ACS, 9.6% had normal troponins and a normal
ECG, 24.9% had normal troponins and an abnormal ECG,
12.6% had elevated troponins and a normal ECG, and 52.9%
had elevated troponins and an abnormal ECG. Patients were
predominantly Caucasian (70.6%) and had a mean age of
59.714.2 years. Overall, participants ruled in for ACS were
older than those ruled out for ACS (61.312.2 versus
10,896 patients screened for eligibility
9,891 did not meet eligibility 
criteria
269 declined to participate
736 were enrolled & provided data
301 ruled-in for ACS
435 ruled-out for ACS
1,005 eligible for study
Figure. Enrollment flowchart. ACS indicates acute coronary
syndromes.
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58.615.4 years, P=0.013; range 21 to 98), were more likely
to have diabetes (31.8% versus 24.6%; P=0.034), more often
male (74.4% versus 55.2%; P=<0.0001), and more likely to be
in the middle-income ranges. ACS was more common among
the income group, ranging from $20 000 to $49 999,
whereas a plurality of patients without ACS were in the
lowest income group (P=0.001). Men had higher rates of
current smoking than women (23.3% versus 14.7%; P=0.003).
Demographic data appear in Table 1 and clinical character-
istics are summarized in Table 2.
Symptom Occurrence by Diagnosis and Sex
Patients ruled in for ACS were more likely to experience chest
pain (71% versus 61%; P=0.006), but less likely to experience
palpitations (19% versus 28%; P=0.008), upper back pain (19%
versus 29%; P=0.001), shortness of breath (46% versus 60%;
P<0.0001), unusual fatigue (34% versus 49%; P<0.0001), and
lightheadedness (36% versus 46%; P=0.006), compared to
patients ruled out for ACS (Table 3). Women ruled in for ACS
were more likely to report arm pain (47% versus 32%;
P=0.021), compared to women ruled out for ACS. Men ruled
in for ACS were more likely to report chest pressure (63%
versus 54%; P=0.035) and chest pain (72% versus 60%;
P=0.005) and less likely to report upper back pain (13%
versus 24%; P=0.004), shortness of breath (41% versus 59%;
P<0.0001), and unusual fatigue (32% versus 48%; P=<0.001).
The mean number of symptoms ranged from 5 to 6 across
groups, and patients in each group reported the full range of
symptoms (1 to 13). There were no differences between
patients ruled in for ACS and those ruled out for ACS or
between women and men for mean number of symptoms.
Table 1. Sample Demographic Characteristics by Diagnosis and Sex
Characteristic
ACS
n=301 (41%)
No ACS
n=435 (59%) P Value
Female
n=272 (37%)
Male
n=464 (63%) P Value
Age (SD) 61.3 (12.2) 58.6 (15.4) 0.013 60.8 (15.2) 59.1 (13.5) 0.127
Sex, n (%) <0.0001
Female 77 (25.6) 195 (44.8)
Male 224 (74.4) 240 (55.2)
Race/ethnicity, n (%) 0.791 0.184
African American 41 (13.6) 67 (15.4) 47 (17.3) 61 (13.1)
White/Non-Hispanic 213 (70.8) 306 (70.3) 191 (70.2) 328 (70.7)
Hispanic 14 (4.7) 20 (4.6) 11 (4.0) 23 (5.0)
Asian 9 (3.0) 13 (3.0) 10 (3.7) 12 (2.6)
Multiracial 11 (3.7) 9 (2.1) 6 (2.2) 14 (3.0)
Other* 11 (3.7) 20 (4.6) 6 (2.2) 25 (5.4)
Missing 2 (0.7) 0 (0.0) 1 (0.4) 1 (0.2)
Education, n (%) 0.730 0.879
<High school diploma 31 (10.3) 48 (11.0) 31 (11.4) 48 (10.3)
High school diploma 71 (23.6) 92 (21.1) 60 (22.1) 103 (22.2)
Some college 104 (34.6) 135 (31.0) 90 (33.1) 149 (32.1)
College degree/graduate work 51 (16.9) 85 (19.5) 54 (19.9) 82 (17.7)
Graduate degree 34 (11.3) 54 (12.4) 29 (10.7) 59 (12.7)
Missing 10 (3.3) 21 (4.8) 8 (2.9) 23 (5.0)
Household income, n (%) 0.001 0.784
<$20 000 67 (22.3) 148 (34.0) 84 (30.9) 131 (28.2)
$20 000 to 49 999 95 (31.6) 111 (25.5) 78 (28.7) 128 (27.6)
$50 000 to 99 999 62 (20.6) 65 (14.9) 43 (15.8) 84 (18.1)
$100 000+ 31 (10.3) 59 (13.6) 32 (11.8) 58 (12.5)
Missing 46 (15.3) 52 (12.0) 35 (12.9) 63 (13.6)
Bolded items are statistically significant. ACS indicates acute coronary syndromes.
*Other race/ethnicity includes Native Hawaiian or Other Pacific Islander, American Indian/Alaska Native.
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Sensitivity and Specificity of Symptoms for a
Diagnosis
Sensitivities for individual symptoms on the checklist ranged
from 27% to 67% for women and 14% to 72% for men
(Table 4). Chest pressure, discomfort, and chest pain dem-
onstrated the highest sensitivity for ACS in both women (66%,
66%, and 67%, respectively) and men (63%, 69%, and 72%,
respectively). Specificities ranged from 33% to 78% for women
and 34% to 78% for men. Six symptoms in particular—
shoulder pain, sweating, palpitations, upper back pain, arm
pain, and indigestion—had higher specificities (>60%), indi-
cating that those patients who did not experience those
symptoms were likely to be ruled out for ACS. Nausea,
however, was specific for men only.
Predictive Value of Symptoms for ACS Diagnosis
Each symptom was tested as a predictor of ACS diagnosis in
models adjusted for data collection site, age, obesity,
diabetes, and functional status. A symptom by sex interaction
term was also tested because there have been previous
reports of sex differences in symptoms.20,21 There were
significant interactions for sex and shoulder pain (P=0.034)
and shortness of breath (P=0.004) (Table 5), meaning that the
relationship between the symptom and ACS diagnosis differed
by sex. Analyses of symptoms stratified by sex indicated that
shoulder pain (OR=2.53; 95% CI=1.29 to 4.96) and arm pain
(OR=2.15; 95% CI=1.10 to 4.20) were predictive of an ACS
diagnosis for women, but not men (OR=1.11; 95% CI=0.67 to
1.85; OR=1.21; 95% CI=0.74 to 1.99, respectively). Shortness
of breath was predictive of a non-ACS diagnosis for men
(OR=0.49; 95% CI=0.30 to 0.79), but was not predictive of a
diagnosis for women (OR=1.36; 95% CI=0.68 to 2.70).
Discussion
The findings that all 3 chest symptoms (pressure, discomfort,
and pain) were sensitive, but not specific, for a diagnosis of
ACS, whereas shoulder and arm pain were predictive of an
ACS diagnosis for women only, are important findings.
Goodacre et al12 also found that pain radiating to either
Table 2. Sample Clinical Characteristics by Diagnosis and Sex
Characteristic
ACS
n=301 (41%)
No ACS
n=435 (59%) P Value
Female
n=272 (37%)
Male
n=464 (63%) P Value
Diabetes, n (%) 92 (31.8) 102 (24.6) 0.034 64 (24.3) 130 (29.5) 0.139
Missing 12 (4.0) 20 (4.6) 9 (3.3) 23 (5.0)
BMI, mean (SD) 29.5 (6.6) 30.3 (7.4) 0.090 29.9 (8.5) 30.1 (6.6) 0.656
BMI categories, n (%) 0.206 0.359
Underweight 5 (1.7) 10 (2.3) 8 (2.9) 7 (1.5)
Normal 69 (22.9) 93 (21.4) 66 (24.3) 96 (20.7)
Overweight 116 (38.5) 135 (31.0) 90 (33.1) 161 (34.7)
Obese 98 (32.6) 164 (37.7) 92 (33.8) 170 (36.6)
Missing 13 (4.3) 33 (7.6) 16 (5.9) 30 (6.5)
Smoking status, n (%) 0.133 0.003
Never 142 (47.2) 235 (54.0) 161 (59.2) 216 (46.6)
Former 77 (25.6) 101 (23.2) 63 (23.2) 115 (24.8)
Current smoker 69 (22.9) 79 (18.2) 40 (14.7) 108 (23.3)
Missing 13 (4.3) 20 (4.6) 8 (2.9) 25 (5.4)
Hypertension, n (%) 195 (64.8) 253 (58.2) 0.095 156 (57.4) 292 (62.9) 0.083
Missing 13 (4.3) 24 (5.5) 12 (4.4) 25 (5.4)
Site <0.0001 0.038
Midwest (n=121) 54 (17.9) 67 (15.4) 49 (18.0) 72 (15.5)
Northwest 1 (n=348) 64 (21.3) 284 (65.3) 138 (50.7) 210 (45.3)
Northwest 2 (n=50) 45 (15.0) 5 (1.1) 10 (3.7) 40 (8.6)
West (n=217) 138 (45.8) 79 (18.2) 75 (27.6) 142 (30.6)
ACS indicates acute coronary syndrome; BMI, body mass index; SD, standard deviation.
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arm was predictive of ACS. However, Goodacre’s study did
not include sex-stratified analyses in the results. Swap and
Nagurney10 also found that chest pain radiating to one or both
shoulders or arms increased the likelihood of an ACS
diagnosis. Lack of sex-stratified analysis has been a contin-
uing problem in understanding the influence of sex on ACS
Table 3. Symptoms Reported for Women and Men by Diagnosis
Symptom
Female Male Total
ACS
(n=77)
No ACS
(n=195) P Value*
ACS
(n=224)
No ACS
(n=240) P Value*
ACS
(n=301)
No ACS
(n=435) P Value*
Chest pressure 66% 64% 0.682 63% 54% 0.035 64% 58% 0.104
Shoulder pain 44% 34% 0.112 27% 29% 0.716 32% 31% 0.880
Sweating 34% 32% 0.754 33% 30% 0.366 34% 31% 0.393
Palpitations 27% 34% 0.295 17% 23% 0.084 19% 28% 0.008
Chest discomfort 66% 69% 0.632 69% 64% 0.215 68% 66% 0.526
Upper back pain 34% 36% 0.740 13% 24% 0.004 19% 29% 0.001
Shortness of breath 58% 61% 0.754 41% 59% <0.0001 46% 60% 0.000
Arm pain 47% 32% 0.021 31% 28% 0.375 35% 29% 0.097
Unusual fatigue 39% 49% 0.146 32% 48% <0.001 34% 49% <0.0001
Nausea 38% 42% 0.557 30% 30% 0.933 32% 35% 0.407
Lightheaded 40% 51% 0.118 34% 42% 0.088 36% 46% 0.006
Chest pain 68% 63% 0.442 72% 60% 0.005 71% 61% 0.006
Indigestion 30% 22% 0.147 18% 23% 0.177 21% 22% 0.658
Mean number of symptoms (SD) 5.91 (3.56) 5.86 (3.26) 0.907 4.82 (2.75) 5.12 (3.25) 0.276 5.10 (3.01) 5.45 (3.27) 0.136
Bolded items are statistically significant. ACS indicates acute coronary syndrome.
*Individual symptoms tested with Pearson chi-square test. Number of symptoms tested with t test.
Table 4. Sensitivity and Specificity of Symptoms for a
Diagnosis by Sex
Symptom*
Females Males
Sensitivity
(%)
Specificity
(%)
Sensitivity
(%)
Specificity
(%)
Chest pressure 66 36 63 41
Shoulder pain 45 67 29 72
Sweating 37 70 33 70
Palpitations 27 66 17 77
Chest discomfort 66 33 69 34
Upper back pain 34 64 14 78
Shortness of
breath
58 39 41 40
Arm pain 49 69 32 72
Unusual fatigue 40 54 32 52
Nausea 38 58 30 70
Lightheaded 40 55 34 58
Chest pain 67 37 72 36
Indigestion 30 78 18 76
Bolded values are considered sensitive and/or specific.
*Model estimated values were adjusted for data collection site.
Table 5. Predictive Value of ACS by Symptoms and Sex
Symptom*
Odds Ratios (CI)
Females Males
Chest pressure 1.63 (0.81, 3.30) 1.34 (0.84, 2.15)
Shoulder pain 2.53 (1.29, 4.96) 1.11 (0.67, 1.85)
Sweating 1.81 (0.91, 3.62) 1.64 (1.00, 2.70)
Palpitations 0.97 (0.49, 1.92) 1.00 (0.56, 1.78)
Chest discomfort 1.07 (0.52, 2.23) 1.18 (0.72, 1.94)
Upper back pain 1.02 (0.52, 1.98) 0.76 (0.42, 1.38)
Shortness of breath 1.36 (0.68, 2.70) 0.49 (0.30, 0.79)
Arm pain 2.15 (1.10, 4.20) 1.21 (0.74, 1.99)
Unusual fatigue 0.94 (0.49, 1.80) 0.72 (0.45, 1.15)
Nausea 1.23 (0.65, 2.33) 1.02 (0.62, 1.67)
Lightheaded 1.22 (0.63, 2.38) 1.09 (0.68, 1.76)
Chest pain 1.38 (0.69, 2.74) 1.50 (0.91, 2.48)
Indigestion 1.87 (0.91, 3.83) 0.80 (0.45, 1.40)
Bolded symptoms are significant. Italicized symptoms showed an interaction effect by
sex in nonstratified models (P<0.05). ACS indicates acute coronary syndrome; CI,
confidence interval.
*Models were adjusted for data collection site, age, obesity, diabetes, and functional
status.
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symptoms.7 Earlier findings have demonstrated that older
patients and patients with diabetes report less chest pain
during ACS.15 Because women are, on average, 10 years
older than men4 when they develop ACS, shoulder and arm
pain (particularly in women) may serve as additional prompts
that aid emergency medical services and triage personnel in
identifying patients with ACS—particularly in the absence of
chest symptoms. Whether these findings apply to women
under age 55 who are at higher risk for mortality and
morbidity, but at lower risk for development of ACS, requires
further study.40 As expected, chest pressure, discomfort, and
pain were sensitive for a diagnosis of ACS in both women and
men.
Patients ruled in for ACS were older than those ruled out
for ACS, more likely to have diabetes, and more often male.
This is consistent with Herlitz et al41 (OR=1.97; 95% CI=1.30
to 2.99) and Edwards et al42 (relative ratio=1.48; 95%
CI=1.00 to 2.18), who found male sex to be an independent
predictor of an ACS diagnosis. In a large meta-analysis,
Haasenritter et al43 found that age (likelihood ratio [LR]=1.44;
95% CI=1.19 to 1.73), diabetes (LR=1.68; 95% CI=1.35 to
2.09), and male sex (LR=1.17; 95% CI=1.08 to 1.27) were
associated with an ACS diagnosis.
Income also differed significantly between the ACS and
non-ACS groups, but in an unanticipated way; patients in the
middle-income levels were more likely to have ACS than those
in the lower-income levels. It is unknown why individuals in
the middle-income ranges were more likely to be ruled in for
ACS. Perhaps, the middle-income groups lack health insur-
ance or are underinsured. This requires further study,
particularly in view of the Affordable Health Care Act.44
Shoulder pain, sweating, palpitations, upper back pain, arm
pain, and indigestion had moderately high specificities for a
non-ACS diagnosis (≥60%) in both women and men. Nausea
had a high specificity for men only. These findings support the
editorial by Canto et al45 suggesting that it is time to
standardize the collection of ACS symptoms in patients
presenting to the ED in order to determine the significance of
sex differences in symptoms of ACS. Lack of specificity of
chest symptoms for a diagnosis of ACS requires further study,
and use of a standardized tool would facilitate comparisons
across studies. In addition, lack of specificity for chest
symptoms could contribute to delays in patient decisions and
in diagnosis because noncardiac chest pain is a common and
costly occurrence.46 Specificities in the 60% to 70% range are
not high enough to preclude the evaluation of ECGs and
troponins in patients presenting to the ED with symptoms
suggestive of ACS, but they may be high enough to design
evidence-based public health messages for the public and
especially for patients at risk for ACS.
Absence of shortness of breath was predictive of a non-
ACS diagnosis in men. This further creates a diagnostic
conundrum in the ED because most patients are undifferen-
tiated on presentation, and streamlined care is an expectation
for potentially life-threatening conditions such as ACS.47
Although there were no sex differences in reports of chest
pain, men with ACS were more likely to experience chest pain,
compared to men without ACS. Reports of sex differences in
chest pain have varied in large database studies and smaller
cohort studies. Some investigators have found that women
are less likely to report chest pain7,21 and some have reported
no differences between women and men.19,48 Our results
suggest that low specificities of symptoms are also likely to
impact ED symptom-based triage. The current approach, in
which a wide net is cast for ACS, appears necessary to avoid
missing a true ACS diagnosis.
The mean number of symptoms experienced by partici-
pants was high, which is important when planning public
health messaging. Being knowledgeable about, and alert for, a
single symptom such as chest pain is not sufficient to make
an informed decision about proper care seeking when
experiencing possible ACS. The public should be informed
that multiple symptoms are likely during ACS. Because the
mean number of reported symptoms exceeded 5 for both
women and men, it is likely that the assessment of individual
symptoms is not sufficient to improve clinical assessment and
decision making.
Strengths
This prospective study was well powered, and symptoms
reported directly by the patients were recorded shortly after
presentation to the ED. The availability of real-time self-report
of dynamic symptoms effectively eliminates recall bias and
increases the internal validity of the findings,49 which has
been a limitation of previous ACS studies. Our 13-item
validated checklist contains symptoms that are empirically
derived from large heterogeneous samples of patients, takes
<1 minute to complete, and is suitable for research and
clinical practice. The demographic and clinical characteristics
of our patients suggest that this sample was representative of
the US population and that there were minimal baseline
differences between patients with and without ACS. Finally,
we adjusted for factors well known to affect symptoms as
reported in the literature.
Limitations
Sampling bias is a limitation to the study. We enrolled only
patients whom ED nurses and physicians deemed to be at risk
for ACS. Therefore, true ACS patients may have been missed
if an ACS diagnosis was not considered. Also, in order to
enroll a sufficient number of patients with confirmed ACS, the
sample was enriched by targeting patients with an abnormal
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ECG or troponin and thus may not be representative of the
individuals presenting to triage. Further, though an abnormal
ECG and troponin were part of the sampling plan, in the final
adjudication (discharge diagnosis) clinicians felt that nearly
10% of patients with normal ECG and troponin levels did have
ACS. Our 13-item validated checklist may have missed other
symptoms; however, patients were asked if they were
experiencing any other symptoms not contained on the list.
Whereas Canto45 has called for the use of a more compre-
hensive symptom instrument, our goal was to use a validated
symptom tool that was suitable for use as a clinical
assessment tool in prehospital and hospital triage as well as
in primary care and research. Finally, patients were only
enrolled between the hours of 0700 and 2300. Hence,
findings may not be generalizable to patients that presented
between 2300 and 0700.
Whereas we believe self-report to be strength of the study,
some have considered it a limitation because there is no way
to externally validate the symptom event. However, Justice
et al33 noted that patients, not providers, experience symp-
toms and so are best able to describe them. Self-reported
symptoms have been independently associated with quality of
life and activities of daily living in patients with acquired
immunodeficiency virus.50 Self-report of symptoms may be
considered superior to symptoms abstracted from the medical
record because there is no way of knowing how accurate the
medical record is or to independently validate which symp-
toms were actually reported by patients. In addition, prudence
is called for in generalizing these findings outside of the ED.
Patients presenting to the ED are a select group that made a
conscious choice to seek care for symptoms judged to be
potentially serious. Therefore, sex differences in symptoms
may be attributable to selection bias in behaviors associated
with a decision to seek assistance, rather than true patho-
physiologic or psychosocial difference in symptoms. A
considerable number of patients with undifferentiated chest
pain were excluded from the study by design because the main
aim was to evaluate sex differences in symptoms among
patients with confirmed ACS. This may have particularly
influenced the findings on specificity of individual symptoms.
Finally, the predictive power of ORs between 1.0 and 2.0 may
be limited and does not support discharging low-risk patients
on the basis of symptoms alone without further testing, such
as ECG and cardiac biomarkers.10
Conclusions
There were more similarities than differences in symptom
predictors of ACS for women and men. Women were twice as
likely to report arm and shoulder pain, compared to men. Sex
differences in symptoms require further study to help guide
patients’ treatment seeking decisions. Although sex differ-
ences were minimal, shoulder pain and arm pain may be key
symptoms that improve clinical prediction of ACS in women.
These symptoms may help guide the clinician in deciding the
extent of diagnostic workups.
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